Memantine LEK
Land: Den europeiske union
Språk: spansk
Kilde: EMA (European Medicines Agency)
Informasjon til brukeren
(PIL)
16-11-2020
Preparatomtale
(SPC)
16-11-2020
Offentlig vurderingsrapport
(PAR)
29-04-2013
Aktiv ingrediens:
clorhidrato de memantina
Tilgjengelig fra:
Pharmathen S.A.
ATC-kode:
N06DX01
INN (International Name):
memantine
Terapeutisk gruppe:
Psychoanaleptics, , Otras drogas anti-demencia
Terapeutisk område:
Enfermedad de Alzheimer
Indikasjoner:
Tratamiento de pacientes con enfermedad de Alzheimer de moderada a grave.
Produkt oppsummering:
Revision: 5
Autorisasjon status:
Autorizado
Autorisasjon dato:
2013-04-21
Informasjon til brukeren
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Les hele dokumentet
Preparatomtale
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Les hele dokumentet
